MedPath

Microneedles for Diagnosis of LTBI

Not Applicable
Terminated
Conditions
Latent Tuberculosis
Interventions
Diagnostic Test: TST vs PPD microneedle test
Registration Number
NCT04552015
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Brief Summary

This study will evaluate new technique, microneedle, to detect latent tuberculosis (TB) in healthy volunteers

Detailed Description

The cross-sectional study to investigate the effect of microneedle formulations and lengths of Tuberculin PPD microneedles on the delayed-type hypersensitivity response in healthy volunteers.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
4
Inclusion Criteria
  1. Sex : Male and Female
  2. Age : 20-60 years
  3. TB contacts or those at risk of TB e.g. health-care workers
  4. HIV-negative healthy individuals
Exclusion Criteria
  1. Presence of an acute infection, as determined by investigators
  2. Receiving immunosuppression drugs e.g. steroids
  3. Having autoimmune diseases e.g. SLE (Systemic Lupus Erythematous)
  4. Being pregnant or breastfeeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
volunteersTST vs PPD microneedle testtwo different types of diagnostic tools (TST vs microneedle) will be used to screen for latent TB infection
Primary Outcome Measures
NameTimeMethod
size of induration at 48 hours post-PPD injection48 hours

Monitoring the response of delayed-type hypersensitivity on the skin by comparing TST to microneedle tests

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Medicine, Chulalongkorn University

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath